Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 5;25(5):2999.
doi: 10.3390/ijms25052999.

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology

Affiliations

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology

Rosanna Rossi et al. Int J Mol Sci. .

Abstract

The need for biomarkers for acute ischemic stroke (AIS) to understand the mechanisms implicated in pathological clot formation is critical. The levels of the brain natriuretic peptides known as brain natriuretic peptide (BNP) and NT-proBNP have been shown to be increased in patients suffering from heart failure and other heart conditions. We measured their expression in AIS clots of cardioembolic (CE) and large artery atherosclerosis (LAA) etiology, evaluating their location inside the clots, aiming to uncover their possible role in thrombosis. We analyzed 80 thrombi from 80 AIS patients in the RESTORE registry of AIS clots, 40 of which were of CE and 40 of LAA etiology. The localization of BNP and NT-BNP, quantified using immunohistochemistry and immunofluorescence, in AIS-associated white blood cell subtypes was also investigated. We found a statistically significant positive correlation between BNP and NT-proBNP expression levels (Spearman's rho = 0.668 p < 0.0001 *). We did not observe any statistically significant difference between LAA and CE clots in BNP expression (0.66 [0.13-3.54]% vs. 0.53 [0.14-3.07]%, p = 0.923) or in NT-proBNP expression (0.29 [0.11-0.58]% vs. 0.18 [0.05-0.51]%, p = 0.119), although there was a trend of higher NT-proBNP expression in the LAA clots. It was noticeable that BNP was distributed throughout the thrombus and especially within platelet-rich regions. However, NT-proBNP colocalized with neutrophils, macrophages, and T-lymphocytes, suggesting its association with the thrombo-inflammatory process.

Keywords: BNP; NT-proBNP; acute ischemic stroke; brain natriuretic peptide; stroke biomarkers; stroke etiology; thrombus.

PubMed Disclaimer

Conflict of interest statement

Authors M.G. and R.M. were employed by the company Cerenovus. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Violin plot showing no difference in BNP expression in clots from patients with LAA (N = 40) or CE stroke etiology (N = 40). (B) Violin plot showing no difference in NT-proBNP expression in clots from patients with LAA (N = 40) or CE stroke etiology (N = 40). Dashed lines represent the median, while dotted lines represent the interquartile ranges, Q1 (lower dotted lines) and Q3 (upper dotted lines). The p value from Mann–Whitney U-test analysis is indicated.
Figure 2
Figure 2
(A) MSB staining of the main clot components. (B,C) Expression of BNP and NT-proBNP in the same clot. BNP expression is located principally within platelet-rich regions, while NT-proBNP expression is only observed in nucleated cells. Higher magnification images are provided in the third row. In the fourth row, negative staining (A) and positive control staining images (pancreatic cancer tissue) for BNP (B) and proBNP (C) are shown. All images were captured using a 20× objective.
Figure 3
Figure 3
Colocalization analysis of NT-proBNP and WBC subtypes in AIS clots, showing individual signals (iiii) and merged images (iv). Top row: T-lymphocytes (CD3); middle row: neutrophils (CD66b); bottom row: macrophages (CD68). All images were captured using a 60× objective (scale bar 5 μm).

References

    1. Alkarithi G., Duval C., Shi Y., Macrae F.L., Ariëns R.A.S. Thrombus Structural Composition in Cardiovascular Disease. Arterioscler. Thromb. Vasc. Biol. 2021;41:2370–2383. doi: 10.1161/ATVBAHA.120.315754. - DOI - PMC - PubMed
    1. Douglas A., Fitzgerald S., Mereuta O.M., Rossi R., O’Leary S., Pandit A., McCarthy R., Gilvarry M., Holmegaard L., Abrahamsson M., et al. Platelet-rich emboli are associated with von Willebrand factor levels and have poorer revascularization outcomes. J. Neurointerv. Surg. 2020;12:557–562. doi: 10.1136/neurintsurg-2019-015410. - DOI - PubMed
    1. Rossi R., Molina S., Mereuta O.M., Douglas A., Fitzgerald S., Tierney C., Pandit A., Brennan P., Power S., O’Hare A., et al. Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry. J. Neurol. 2022;269:1913–1920. doi: 10.1007/s00415-021-10758-5. - DOI - PMC - PubMed
    1. Fitzgerald S., Rossi R., Mereuta O.M., Jabrah D., Okolo A., Douglas A., Gil S.M., Pandit A., McCarthy R., Gilvarry M., et al. Per-pass analysis of acute ischemic stroke clots: Impact of stroke etiology on extracted clot area and histological composition. J. Neurointerv. Surg. 2021;13:1111–1116. doi: 10.1136/neurintsurg-2020-016966. - DOI - PMC - PubMed
    1. Ntaios G., Papavasileiou V., Makaritsis K., Milionis H., Michel P., Vemmos K. Association of ischaemic stroke subtype with long-term cardiovascular events. Eur. J. Neurol. 2014;21:1108–1114. doi: 10.1111/ene.12438. - DOI - PubMed